Introduction
Management guidelines for tricuspid regurgitation (TR) remain vague 1 due to paucity of outcome studies and their contradictory results and provide little guidance in patients with left ventricular systolic dysfunction (ejection fraction, EF < 50%). On one hand, studies 2,3 suggested increased mortality among patients with significant TR, independent of left ventricular EF. On the other hand, recent data emphasized that the prognostic impact of TR in the context of systolic dysfunction depends on the severity of heart failure and is linked to mortality only in patients with milder heart failure, but provides no additive value in advanced disease when compared with established risk factors. 4 Furthermore, the heterogeneity of TR 5 and imprecision of standard assessment of TR 6 may have obscured the specific significance of TR and the thresholds at which attention should be focused on TR. While clinical guidelines 1, 7 propose Class I indications for tricuspid valve surgery when there is another surgical indication such as severe mitral valve disease, in patients with left ventricular systolic dysfunction little guidance is offered. These gaps in knowledge are particularly important to address as new devices are currently evaluated to treat TR, 8, 9 while specific risks attached to TR are poorly known, especially in the context of left ventricular dysfunction. In filling these gaps of knowledge and resolving these dilemmas, we aimed at analysing the outcome of TR in patients with left ventricular systolic dysfunction in a cohort in which prospective quantitative assessment of TR was performed.
Methods
Definition of tricuspid regurgitation in patients with systolic dysfunction:
The diagnosis of TR due to systolic left ventricular dysfunction required (i) presence of systolic dysfunction (EF < 50%); (ii) absence of other organic valve disease; and (iii) absence of previous valve surgery. We first excluded all patients with congenital TR (any congenital heart disease resulting in TR including atrial septal defect), organic associated TR (TR not due to congenital disease and associated with structural tricuspid disease), TR associated with other valvular disease (TR neither congenital nor organic and occurring in patient with valve prostheses, repair, any degree of mitral stenosis, or any other native organic valve disease of at least moderate degree). We then excluded all patients with normal systolic function (EF > _50%). The remaining patients had abnormal systolic function (EF < 50%), no other significant valvular or congenital disease, and functional TR ranging from none to severe.
Study design
In 1995, we initiated a prospective programme of TR quantitation enrolling patients with mild or greater holo-systolic TR by visual assessment. The final population was selected retrospectively as all consecutive patients with TR in the context of systolic dysfunction with TR quantitation performed from 1995 to 2005. Guidelines 10 advocate grading TR severity using an integrative, semi-quantitative approach including multiple echo parameters. To examine the hypothesis that the use of a simpler approach, using cut-offs based on a single quantitative parameter [Proximal iso-velocity surface area (PISA) calculated effective orifice area (ERO)] may have additive prognostic value, and that TR of increasing quantified degree in patients with systolic dysfunction is associated with poorer outcome, we categorized the final cohort into the three categories: trivial TR (ERO = 0), mild-moderate ERO >0 but <0.4 cm 2 , and severe TR (ERO > _ 0.4 cm 2 ). For matching of cases (TR associated with systolic dysfunction with mild to severe quantified regurgitation) to controls (patients with systolic dysfunction and trivial TR) a frequency matching approach was used. Patients with trivial TR (with ERO = 0, jet area < _1.0 cm 2 ) were randomly selected from the desired bin of all patients with trivial TR, with similar eligibility criteria, and systolic dysfunction (EF <50%) in the computerized Mayo Clinic echo database, achieving groups of patients with trivial and mild to severe (ERO > 0) quantified TR comparable in terms of other independent determinants of outcome but with no set couples of matched patients and unequal size. The predefined baseline computerized matching parameters were age (within 5 years), gender, EF (within 5%), exact year of diagnosis, co-morbidity index (within 0.2), and systolic TR peak velocity (within 0.2 m/s). Thus, all patients of the Quantitative Cohort had systolic dysfunction diagnosed homogeneously with similar eligibility criteria and were differentiated only by severity of TR. The study was approved by our institutional review board.
Baseline clinical assessment and management
Patients' symptoms, baseline physical examination findings, and comorbid conditions summarized as the Charlson age-adjusted comorbidity index, were evaluated by the patients' Mayo personal physician. Atrial fibrillation was ascertained by each patient's personal cardiologist. Congestive heart failure was diagnosed on the basis of Framingham criteria. 11 Briefly, the diagnosis of right heart failure required two major or one major and two minor criteria to present concurrently. The major criteria for right heart failure included elevated JVP, right heart distension by imaging, hepatojugular reflux, and signs of visceral congestion. Minor criteria included bilateral ankle oedema, dyspnoea on ordinary exertion, hepatomegaly, pleural effusion, or weight loss > _4.5 kg in 5 days in response to treatment of congestive heart failure. Liver dysfunction was defined based on either: mild elevations (at least X1.5 the upper normal limit) of either aspartate aminotransferase, alanine aminotransferase, gamma-glutamyl transferase and/or alkaline phosphatase, or any increase in total and direct bilirubin, with or without decrease in albumin below the lower limit. Renal dysfunction was defined as estimated glomerular filtration rate (MDRD-GFR equation) <60 mL/min per 1.73 m 2 body surface area. Data were collected by the patients' personal physicians including the Doppler echocardiographic and clinical assessment during the same episode of care before any change in medical regiment, or surgery was considered. Treating physicians were responsible for implementing contemporary heart failure guidelines 12, 13 in all patients, reflecting routine clinical practice. Surgical indication was based only on severe TR combined with right heart failure symptoms in all patients. 14 Not all patients with effort intolerance or shortness of breath and severe TR were referred to surgery, given that effort intolerance and dyspnoea could also be associated with left ventricular dysfunction, comorbidities, body habitus, chrontropic incompetence, skeletal muscle dysfunction, or poor physical fitness.
Follow-up and outcomes
Clinical follow-up was obtained after all matching processes were completed, by review of medical records, surveys, and telephone interviews.
Outcome analysis started at time of prospective TR quantitation. Events used as end points were all cause mortality and cardiovascular events under medical management. Cardiovascular events comprised death, new onset of atrial fibrillation and any admission for heart failure during follow-up.
Doppler echocardiography
All patients had comprehensive two-dimensional and Doppler echocardiography using multiple windows during the same examination. Patients were instructed to breathe normally and all tricuspid, and right ventricular measurements were averages of inspiratory and expiratory measurements 15 over at least five cardiac cycles in sinus rhythm and eight cycles in atrial fibrillation performed according to guidelines of the American Society of Echocardiography. 16 Right ventricular size and systolic function were qualitatively graded in a four scale and two scale (< or > _moderate) grading system. 17, 18 The size of the right ventricle was assessed semiquantitatively and compared with the size of the left ventricle. The right ventricle was considered normal if it was two-thirds or less in size compared with the left ventricle. The right ventricle was at least mildly enlarged if it was the same size as the left ventricle and at least moderately enlarged if it was larger than the left ventricle and occupied the apex. Semi-quantitative assessment of right ventricular systolic function integrated visual assessment of right ventricular contractility of the right ventricular free wall, right ventricular apex, right ventricular outflow tract, and inter-ventricular septum from multiple views including the parasternal log axis, short axis, apical four-chamber, apical long-and short-axis, Outcome of TR in systolic dysfunction and sub-costal views, and integrated visual assessment of the displacement of the tricuspid annulus. 17, 19 Haemodynamic assessment measured the tricuspid regurgitant velocity and estimated right atrial pressure using the inferior vena cava to calculate the systolic pulmonary artery pressure. 20 Forward stroke volume was calculated from left ventricular outflow tract with subsequent calculation of cardiac output and index. Tricuspid regurgitation was assessed by standard qualitative assessment 1 and by quantitative measures. 6, 21 Tricuspid regurgitation quantitation used proximal flow convergence (PISA) method as validated previously. 6, 15, 22 Briefly, colour Doppler images of TR PISA were obtained from apical or para-apical views, using a zoom of the region of interest. Transducer's position was optimized to minimize the angle between centreline of regurgitant flow and ultrasonic beam. Colour-flow scale was maximized and baseline shifted downward until the flow convergence region was clearly visualized. Standard corrections for systolic leaflets-angle and for ratio of aliasing velocity to peak TR velocity were applied 6, 21 allowing calculation of regurgitant flow, effective regurgitant orifice area, and regurgitant volume. Apart from qualitative grading, right ventricular function was evaluated by right ventricular fractional area change, and index of myocardial performance (Tei index). 7 The right ventricular FAC was defined as (end-diastolic area -end-systolic area)/end-diastolic area and was obtained by tracing the right ventricular endocardium both in systole and diastole from the annulus, along the free wall to the apex, and then back to the annulus, along the septum. The Tei index, is a global estimate of both systolic and diastolic function of the right ventricle and was 
Statistical analysis
Descriptive results were expressed as mean ± standard deviation for continuous variables and as percentages for categorical variables. Group comparisons used ANOVA and Tukey-Kramer test for post hoc multiple comparisons, the Fisher's exact test or v 2 test, as appropriate. To analyse the association of TR with manifestations of heart failure we performed binary logistic regression models with nominal parameters of heart failure [New York Heart Association (NYHA) 3-4, hepato-jugular-reflux, elevated jugular venous pressure (JVP), oedema, liver dysfunction, right ventricular enlargement, and renal dysfunction] as dependent variables and TR severity subsets (stratified as severe, mild to moderate, vs. trivial TR) as independent variable. Cox proportional hazards models for the endpoints allowed calculation of hazard ratios (HRs) attached to of ERO > _0.4 cm To assess if TR ERO as a continuous parameter is associated with outcome we used Cox proportional hazards models for the endpoint (time to death or cardiac event) allowing calculation of HR attached to ERO. endpoints were death from any cause and cardiac events under medical management (from diagnosis to surgery or death), and data were censored at the time of cardiac surgery if it was performed. Time of follow-up was calculated between echo diagnosis and either death, cardiac event, or last date of follow-up. The survival estimate was calculated using the Kaplan-Meier method and compared by log-rank test. P-values <0.05 were considered significant. All authors participated in designing the study, collecting and analysing data, and drafting and revising the manuscript.
Inter-observer and intra-observer variability
Inter-observer variability was determined by a second independent blinded observer who measured the echo variables in 50 randomly selected patients. Intra-observer variability was determined by having the second observer who measured the data in all patients re-measure the echo variables in 50 patients 1 month apart. Inter-observer and intraobserver variability were assessed using the Bland-Altman method and the within-subject coefficient of variation. The within-subject coefficient of variation (calculated as the ratio of the standard deviation of the measurement difference to the mean value of all measurements) provides a scale-free, unitless estimate of variation expressed as a percentage. We measured intra-observer and inter-observer reproducibility for PISA radius, CW peak velocity, ERO, and regurgitant volume and expressed them using the coefficient of variation.
Results

Baseline characteristics
The comparison for core pre-defined criteria: age (70.2 ± 11 vs. 69.7 ± 12 years; P = 0.9), sex (female 32 vs. 31%; P = 0.8), left ventricular EF (31.3 ± 10 vs. 31.3 ± 9%; P = 0.9), comorbidity index (5.2 ± 2.2 vs. 5.1 ± 2; P = 0.9), and systolic TR peak velocity (3.2 ± 0.5 vs.
3.2 ± 0.5 m/s; P = 0.8) verified that the matching process of cases (TR associated with systolic dysfunction with mild to severe quantified regurgitation) to controls (patients with systolic dysfunction and trivial TR) was successful as all parameters were equally distributed. Table 1 shows the baseline characteristics and echo assessments of the 291 patients enrolled in the quantitative cohort, stratified as severe TR (ERO > _ 0.4 cm 2 ), mild to moderate quantified TR (ERO < 0.4 cm 2 but >0.1 cm 2 ), vs. trivial TR (systolic dysfunction with trivial TR). Echo assessment showed no differences in EF, or systolic pulmonary pressure (SPAP), but worsening left ventricular diastolic function, right atrial pressure, LA volume and cardiac index with deteriorating TR. Clinical characteristics show increasing prevalence of murmur with severe regurgitation, although inconsistent and rarely with inspiratory variation.
Association of tricuspid regurgitation with manifestations of heart failure Table 2 shows the baseline descriptors of heart failure by TR severity subsets stratified as severe, mild to moderate, vs. trivial TR. Overall, the TR severity was strongly related to all clinical and echocardiographic measures of heart failure. The prevalence of severe heart failure signs was considerable in patients with ERO > _ 0.4 cm 2 . For example, signs of right heart failure were found in 49% of patients with severe TR while oedema was present in 65%. Of note, only five patients defined to have right heart failure did not have pedal oedema. Table 3 shows the odds ratio of multivariable analysis for association of TR degree and parameters of heart failure adjusted for age, sex, EF, right ventricular dysfunction, and systolic PA pressure. These analyses suggest that worsening TR is strongly associated with worse specific right ventricular failure parameters even in adjusted analyses. 
Survival after diagnosis in the quantitative cohort
There were 167 deaths during follow-up [1.9 (0.5-6.6) years] after diagnosis. Thus, survival rates overall were 78 ± 2, 54 ± 3, and 41 ± 4% ) was independently associated with mortality (HR 1.6, 1.15-2.3; P = 0.006, Table 4 ; Take home figure) and improved the model predictive power.
As continuous variables ERO and regurgitant volume of TR were associated with adjusted HR of 1.2 (1.09-1.38), P = 0.03 for 0.1 cm 2 and 1.08 (1.03-1.14), P = 0.002 for 10 mL with mortality, respectively. Because visual assessment of right ventricular function is limited and right ventricular function and remodelling may have an impact on patient outcomes we assessed the impact of TR on outcome adjusted for right ventricular index of myocardial performance (RIMP) and right ventricular fractional area change. The addition of either right ventricular fractional area change, or RIMP to the multivariable analysis (instead of the qualitative right ventricular dysfunction> _ moderate) did not change the significant association between severe TR (defined using an ERO > _0.4 cm 2 ) and mortality (for right ventricular fractional area change HR 1.7 (1.08-2.6); P = 0.02 and 2.1 (1.13-4.4); P = 0.02 for mortality and combined outcome, respectively; for RIMP HR 2.6 (1.14-6.5); P = 0.02 and 2.2 (1.13-4.8); P = 0.02 for mortality and combined outcome, respectively).
Analysing whether other characteristics affected TR severity impact on survival after diagnosis, no interaction was found with atrial fibrillation, pulmonary hypertension (SPAP > 50 mmHg), mitralregurgitation (> _moderate), symptoms (NYHA > _III), EF (<35%), and right ventricular dysfunction (> _moderate)-All P > 0.1. ) was independently associated with higher event rate (adjusted HR 1.9 (1.4-2.7); P < 0.0001, Table 4 ; Take home figure) and improved the model predictive power (P < 0.01).
Cardiac events after diagnosis
Kaplan-Meier survival curve ( Figure 2 ) shows higher event rate after diagnosis with severe compared with lesser degrees of TR (ERO > _ 0.4 cm 2 vs. <0.4 cm 2 ) at 5years (P < 0.0001). Analysing whether other characteristics affected the impact of TR severity on cardiac events after diagnosis, no interaction was found with atrial fibrillation, pulmonary hypertension (SPAP > 50 mmHg), mitralregurgitation (> _moderate), symptoms (NYHA > _III), EF (<35%), and right ventricular dysfunction (> _moderate)-All P > 0.1.
Clinical management and surgery
Clinical management of TR after diagnosis was solely medical in 282 patients (97%) and was medical followed by tricuspid surgery [median 1.9 (0.3-4.7) years later] in nine patients. Surgical indication was based on severe right heart failure symptoms in all patients. Tricuspid regurgitation was severe at surgery in all operated patients and valve repair was performed in 8 (89%) while replacement with a bioprosthesis was performed in one.
Intra-observer and inter-observer variability
Comparison of intra-observer echo variables showed good agreement between measurements: PISA radius (mean difference 0.1 ± 0.05 m, r = 0.98, P = 0.2), CW peak velocity (mean difference 0.005 ± 0.03 m/s, r = 0.94, P = 0.9), ERO (mean difference 0.007 ± 0.009 cm, r = 0.95, P = 0.5), regurgitant volume (mean difference 1.0 ± 1.0 mL, r = 0.93, P = 0.3). The Bland-Altman plot showed a random scatter of points around 0, indicating no systematic bias or measurement error proportional to the measurement value. Measurement variability [within-subject coefficient of variation and 95% confidence interval (CI) of the Bland-Altman method] for measurements of intra-observer differences was as follows: PISA radius, 0.6%; CW peak velocity, 0.8%; ERO, 1.9%, and regurgitant volume, 2.0%.
Comparison of inter-observer timing intervals showed good agreement as well: PISA radius (mean difference 0.4 ± 0.09 mm, r = 0.97, P = 0.1), CW peak velocity (mean difference 0.006 ± 0.03 m/ s, r = 0.93, P = 0.8), ERO (mean difference 0.008 ± 0.009 cm, r = 0.96, P = 0.4), and regurgitant volume (mean difference 0.14 ± 1.1 mL, r = 0.92, P = 0.9). The Bland-Altman plot showed a random scatter of points around 0, indicating no systematic bias or measurement error proportional to the measurement value. Measurement variability (within-subject coefficient of variation and 95% CI of the BlandAltman method) for measurements of inter-observer differences was as follows: PISA radius, 1.1%; CW peak velocity, 0.8%; ERO, 1.8%, and regurgitant volume, 2.4%.
Discussion
The present study based on a large cohort with uniform diagnosis of left ventricular systolic dysfunction, with TR quantitative assessment and with matched control-group of not only similar age and sex but also similar EF and TR velocity, provides insights into the importance of TR in this clinical context. Indeed, functional TR, even moderate, is an independent determinant of more severe heart failure at diagnosis either clinically assessed or measured by Doppler echocardiography. during follow-up TR, even severe, is very rarely surgically treated and TR with ERO > _ 0.4 cm 2 was associated with excess mortality and excess event-rates, independently of baseline characteristics and without differing effect in any group. Hence, our study focused on a specific aetiology complex provides important information regarding TR-related gaps of knowledge, thresholds of severity and impact on outcome and should lead to large-scale studies and clinical trials of treatment of functional TR. The task of defining the impact of TR on outcome is difficult because it is a heterogeneous condition 23 that may variably be associated with intrinsic valve lesions, pulmonary hypertension, ventricular dysfunction, atrial fibrillation, comorbid, or causal diseases. 5 These highly variable circumstances of age, previous cardiac surgery, other valvular diseases, comorbid conditions, or haemodynamic alterations have confused previous attempts at defining its specific impact on outcome. This is further complicated by the imprecision of qualitative grading of TR. Thus, reports can be found suggesting that TR seriously affects outcome, 3, 24 opposed by others reporting that the most severe tricuspid lesions are benign. 25 To fill these gaps of knowledge,
we designed the present study based on careful selection of patients The study was designed to assess the influence of quantitatively assessed TR on survival and cardiac events (mortality, heart failure, and new onset atrial fibrillation) in univariate analysis and adjusted for numerous clinical and cardiac associated conditions. Outcome TR is often clinically unsuspected with diagnosis affirmed at an advanced stage, with congestive heart failure, and right-sided chamber dilatation. 23, 26, 27 As noted in the present study, and our previous report 27 cardiac auscultation and physical examination are rarely typical.
Thus, in routine practice diagnosis mostly depends on comprehensive Doppler echocardiography ordered for symptoms often atypical such as fatigue or effort intolerance. For the purpose of grading, we prefer quantitative methods, which are the most powerful predictors of outcome. 27 Our quantitative prospective analysis showed that TR in patients with systolic dysfunction can be severe or even massive in degree (>100 mL/beat of regurgitant volume and >1.5 cm 2 of regurgitant orifice). The threshold of ERO >0.4 cm 2 was suggested by physiologic studies, 22 and linked to outcome in patients with isolated TR, 27 but the present data is the first to link this threshold to survival and cardiac events, in patients with systolic dysfunction. Importantly, lesser degree of TR was not associated with increased mortality further emphasizing the importance of precise TR assessment, preferentially using quantitative measurements. 27 Nevertheless, although we have observed an increased risk for mortality and cardiac events, with threshold of severe TR similar to the threshold in isolated TR, 27 it is very important to follow with a larger cohort to judge in particular if moderate TR has a prognostic role. Finally, we show that surgical correction is rarely performed in patients with TR, linked to low awareness of physicians to the regurgitation severity.
Subgroup analysis
Importantly, severe (but not lesser degrees of TR) was associated with excess mortality and cardiac events (mostly rehospitalizations for diuretic therapy) even when adjusted for established risk factors. As opposed to the data recently presented by Neuhold et al. 4 we did not find significant interactions between TR, degree of heart failure, left or right ventricular systolic function. However, the lack of interaction between TR and outcome in the different Subgroup analyses in our study should be interpreted with caution due to the small number of patients, large confidence intervals, and possible underpower. Thus our results should serve as incentive to explore the issue of outcome of TR in the future with large series and welldesigned clinical trials.
Clinical implications
According to current guidelines, 1, 7 surgical correction of functional TR may be considered in symptomatic patients with severe TR, and at the time of left-sided valve surgery even when only mild or moderate if it is associated with annular dilatation. However, our actual knowledge about the optimal timing and mode of TR surgery as well as appropriate indications for surgical treatment are limited. Very recently, we have published the outcome data of 189 patients who underwent tricuspid valve replacement. 28 The results of that study showed good outcomes of tricuspid valve replacement in patients who were not highly symptomatic and did not have severe right ventricular dysfunction. Based on our present analysis, the clinical impact of TR in the context of left ventricular systolic dysfunction is significant, thus we believe that if the risk of surgery is low, our study strengthen the rational for early intervention to reduce TR before severe right ventricular dysfunction or symptoms occur. Nevertheless, we believe it is essential to consider larger trials in patients with left ventricular systolic dysfunction to conclude whether severe TR affects survival in this context.
Study limitations
This was a single-centre, observational study. Due to its observational nature the study is subject to selection bias and its results imply association and not cause and effect. The study was conducted between 1995 and 2005 and the management of heart failure has evolved considerably since then. Nevertheless, the use of ACE inhibitors, Beta blockers and limited use of Spironolactone were already advocated at the time and were used accordingly in our cohort. 13 The PISA method has several limitations in patients with functional TR including lack of circularity of regurgitant orifice in most patients, validation only in several small studies and possible underestimation of the severity of TR. The lack of interaction between TR and outcome in the different subgroup analyses should be interpreted with caution due to the small number of patients, large confidence intervals, and possible under-power. At the time of patient enrolment, routine right ventricular assessment did not include magnetic resonance imaging, right ventricular strain analysis, or three-dimensional right ventricular EF, the prognostic value of which will warrant prospective studies of TR in the future. 
Conclusions
Our quantitative study of functional TR in the uniform context of isolated left ventricular dysfunction shows that TR, even moderate, is associated at diagnosis with more severe heart failure presentation. Furthermore, severe TR seems to contribute independently to lower survival and higher rates of cardiac events. Nevertheless we acknowledge the fact that we cannot conclusively prove that ERO predicts outcome because other possibly significant comorbidities may have been not adequately elucidated. While it is yet unknown whether these patients may benefit from correction of TR this observation is important and should lead to consideration of larger studies and therapeutic trials. Thus, TR is an important finding in the context of left ventricular systolic dysfunction and should be carefully quantified and graded with the hope that therapeutic interventions may be demonstrated to reduce these patients' considerable mortality.
